Barclays’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Barclays’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31M	Hold	5,288	–	–	﹤0.01%	2631
2026 Q1	$1.06M	Buy	+5,288	New	+$1.09M	﹤0.01%	2721
2025 Q4	–	Sell	-5,288	Closed	-$948K	–	5373
2025 Q3	$948K	Buy	+5,288	New	+$901K	﹤0.01%	3398
2023 Q2	–	Sell	-72	Closed	-$11.2K	–	4704
2023 Q1	$11.2K	Hold	72	–	–	﹤0.01%	4741
2022 Q4	$11.1K	Hold	72	–	–	﹤0.01%	4912
2022 Q3	$10K	Hold	72	–	–	﹤0.01%	4295
2022 Q2	$10K	Hold	72	–	–	﹤0.01%	4623
2022 Q1	$11K	Hold	72	–	–	﹤0.01%	4583
2021 Q4	$12K	Hold	72	–	–	﹤0.01%	3984
2021 Q3	$12K	Hold	72	–	–	﹤0.01%	4492
2021 Q2	$12K	Hold	72	–	–	﹤0.01%	4592
2021 Q1	$12K	Hold	72	–	–	﹤0.01%	4419
2020 Q4	$12K	Hold	72	–	–	﹤0.01%	4734
2020 Q3	$11K	Hold	72	–	–	﹤0.01%	4990
2020 Q2	$12K	Hold	72	–	–	﹤0.01%	5301
2020 Q1	$9K	Sell	72 -370	-84%	-$52.7K	﹤0.01%	5839
2019 Q4	$66K	Sell	442 -69	-14%	-$9.48K	﹤0.01%	5661
2019 Q3	$63K	Hold	511	–	–	﹤0.01%	5777
2019 Q2	$72K	Sell	511 -67	-12%	-$9.25K	﹤0.01%	5906
2019 Q1	$87K	Hold	578	–	–	﹤0.01%	5473
2018 Q4	$72K	Hold	578	–	–	﹤0.01%	5256
2018 Q3	$92K	Sell	578 -67	-10%	-$10.1K	﹤0.01%	5620
2018 Q2	$90K	Hold	645	–	–	﹤0.01%	5314
2018 Q1	$86K	Hold	645	–	–	﹤0.01%	5487
2017 Q4	$80K	Hold	645	–	–	﹤0.01%	5413
2017 Q3	$80K	Hold	645	–	–	﹤0.01%	5078
2017 Q2	$74K	Hold	645	–	–	﹤0.01%	5113
2017 Q1	$68K	Hold	645	–	–	﹤0.01%	5155
2016 Q4	$59K	Hold	645	–	–	﹤0.01%	5057
2016 Q3	$64K	Hold	645	–	–	﹤0.01%	4830
2016 Q2	$58K	Buy	+645	New	+$59.2K	﹤0.01%	4753

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Barclays's FBT Position: Q2 2026 in Review

Barclays held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 5,288 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2631.

Barclays first reported a position in FBT in Q2 2016 and has held it in 31 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Barclays held 5,288 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.31M as of Q2 2026.
Barclays left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2631 holding.
Barclays first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2016 and has held it in 31 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.